Chinese General Practice ›› 2024, Vol. 27 ›› Issue (11): 1380-1386.DOI: 10.12114/j.issn.1007-9572.2023.0627
• Original Research • Previous Articles Next Articles
Received:
2023-09-30
Revised:
2023-11-10
Published:
2024-04-15
Online:
2024-01-23
Contact:
ZHAO Yang, OUYANG Jiang, LIN Xiuquan
通讯作者:
赵洋, 欧阳江, 林修全
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0627
25岁及以上人群分类 | 死亡人数(万) | 粗死亡率 | 标化死亡率 | |||||
---|---|---|---|---|---|---|---|---|
1990年 | 2019年 | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | |
总体 | 29.805(20.830~41.454) | 70.034(48.107~102.695) | 49.55(34.63~68.92) | 67.30(46.23~98.69) | 0.36(0.06~0.75) | 46.92(32.56~68.51) | 41.26(27.54~62.46) | -0.12(-0.32~0.10) |
男性 | 14.771(10.286~20.850) | 40.537(27.305~59.841) | 47.82(33.30~67.50) | 77.88(52.46~114.97) | 0.63(0.18~1.21) | 53.33(36.36~77.28) | 55.85(36.10~86.57) | 0.05(-0.23~0.37) |
女性 | 15.034(10.145~21.346) | 29.497(18.825~45.089) | 51.38(34.67~72.95) | 56.72(36.20~86.70) | 0.10(-0.22~0.53) | 43.00(28.58~62.16) | 31.24(19.73~48.62) | -0.27(-0.48~-0.01) |
25~49岁 | 1.415(0.789~2.288) | 2.149(1.258~3.335) | 3.46(1.93~5.59) | 3.81(2.23~5.92) | 0.10(-0.17~0.49) | |||
50~69岁 | 10.683(7.421~15.091) | 16.325(11.153~22.693) | 69.35(48.17~97.96) | 44.25(30.23~61.52) | -0.36(-0.51~-0.16) | |||
≥70岁 | 17.707(11.766~26.487) | 51.560(33.285~79.768) | 462.84(307.53~692.32) | 477.57(308.29~738.83) | 0.03(-0.23~0.33) |
Table 1 The number of deaths from cardiovascular diseases attributable to diabetes in people aged 25 years and above in China and their changes in mortality in 1990 and 2019
25岁及以上人群分类 | 死亡人数(万) | 粗死亡率 | 标化死亡率 | |||||
---|---|---|---|---|---|---|---|---|
1990年 | 2019年 | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | |
总体 | 29.805(20.830~41.454) | 70.034(48.107~102.695) | 49.55(34.63~68.92) | 67.30(46.23~98.69) | 0.36(0.06~0.75) | 46.92(32.56~68.51) | 41.26(27.54~62.46) | -0.12(-0.32~0.10) |
男性 | 14.771(10.286~20.850) | 40.537(27.305~59.841) | 47.82(33.30~67.50) | 77.88(52.46~114.97) | 0.63(0.18~1.21) | 53.33(36.36~77.28) | 55.85(36.10~86.57) | 0.05(-0.23~0.37) |
女性 | 15.034(10.145~21.346) | 29.497(18.825~45.089) | 51.38(34.67~72.95) | 56.72(36.20~86.70) | 0.10(-0.22~0.53) | 43.00(28.58~62.16) | 31.24(19.73~48.62) | -0.27(-0.48~-0.01) |
25~49岁 | 1.415(0.789~2.288) | 2.149(1.258~3.335) | 3.46(1.93~5.59) | 3.81(2.23~5.92) | 0.10(-0.17~0.49) | |||
50~69岁 | 10.683(7.421~15.091) | 16.325(11.153~22.693) | 69.35(48.17~97.96) | 44.25(30.23~61.52) | -0.36(-0.51~-0.16) | |||
≥70岁 | 17.707(11.766~26.487) | 51.560(33.285~79.768) | 462.84(307.53~692.32) | 477.57(308.29~738.83) | 0.03(-0.23~0.33) |
25岁及以上人群分类 | DALY(万人年) | 粗DALY率 | 标化DALY率 | |||||
---|---|---|---|---|---|---|---|---|
1990年 | 2019年 | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | |
总体 | 665.747(475.204~912.111) | 1 358.585(967.971~1 886.722) | 1 106.83(790.05~1 516.42) | 1 305.62(930.23~1 813.16) | 0.18(-0.06~0.48) | 855.75(611.48~1 172.90) | 714.60(501.88~1 021.96) | -0.16(-0.33~0.03) |
男性 | 346.125(243.267~481.851) | 819.054(563.153~1 184.300) | 1 120.56(787.57~1 559.97) | 1 573.59(1 081.95~2 275.31) | 0.40(0.06~0.87) | 944.12(664.68~1 315.48) | 932.96(644.51~1 340.08) | -0.01(-0.26~0.29) |
女性 | 319.622(223.298~453.038) | 539.531(366.478~776.862) | 1 092.33(763.14~1 548.29) | 1 037.42(704.67~1 493.77) | -0.05(-0.30~0.26) | 786.68(544.89~1 110.93) | 534.32(361.79~787.62) | -0.32(-0.49~-0.11) |
25~49岁 | 73.375(41.529~118.277) | 112.363(65.805~172.740) | 179.32(101.49~289.06) | 199.32(116.73~306.43) | 0.11(-0.15~0.47) | |||
50~69岁 | 318.149(221.939~448.608) | 510.605(355.157~702.862) | 2 065.20(1 440.67~2 912.05) | 1 384.19(962.79~1 905.38) | -0.33(-0.47~-0.14) | |||
≥70岁 | 274.223(182.954~404.091) | 735.617(485.415~1 123.563) | 7 167.67(4 782.07~10 562.18) | 6 813.49(4 496.04~10 406.75) | -0.05(-0.28~0.22) |
Table 2 The changes in DALY and DALY rate of cardiovascular diseases attributable to diabetes among the Chinese population aged 25 years and above in 1990 and 2019
25岁及以上人群分类 | DALY(万人年) | 粗DALY率 | 标化DALY率 | |||||
---|---|---|---|---|---|---|---|---|
1990年 | 2019年 | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | |
总体 | 665.747(475.204~912.111) | 1 358.585(967.971~1 886.722) | 1 106.83(790.05~1 516.42) | 1 305.62(930.23~1 813.16) | 0.18(-0.06~0.48) | 855.75(611.48~1 172.90) | 714.60(501.88~1 021.96) | -0.16(-0.33~0.03) |
男性 | 346.125(243.267~481.851) | 819.054(563.153~1 184.300) | 1 120.56(787.57~1 559.97) | 1 573.59(1 081.95~2 275.31) | 0.40(0.06~0.87) | 944.12(664.68~1 315.48) | 932.96(644.51~1 340.08) | -0.01(-0.26~0.29) |
女性 | 319.622(223.298~453.038) | 539.531(366.478~776.862) | 1 092.33(763.14~1 548.29) | 1 037.42(704.67~1 493.77) | -0.05(-0.30~0.26) | 786.68(544.89~1 110.93) | 534.32(361.79~787.62) | -0.32(-0.49~-0.11) |
25~49岁 | 73.375(41.529~118.277) | 112.363(65.805~172.740) | 179.32(101.49~289.06) | 199.32(116.73~306.43) | 0.11(-0.15~0.47) | |||
50~69岁 | 318.149(221.939~448.608) | 510.605(355.157~702.862) | 2 065.20(1 440.67~2 912.05) | 1 384.19(962.79~1 905.38) | -0.33(-0.47~-0.14) | |||
≥70岁 | 274.223(182.954~404.091) | 735.617(485.415~1 123.563) | 7 167.67(4 782.07~10 562.18) | 6 813.49(4 496.04~10 406.75) | -0.05(-0.28~0.22) |
25岁及以上人群分类 | 粗死亡率 | 标化死亡率 | ||||
---|---|---|---|---|---|---|
1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | |
缺血性心脏病 | ||||||
总体 | 15.83(9.71~24.88) | 32.84(18.62~53.62) | 1.07(0.59~1.68) | 16.36(9.05~26.27) | 21.10(11.47~35.35) | 0.29(0.04~0.59) |
男性 | 15.52(9.49~24.15) | 36.64(20.53~58.73) | 1.36(0.71~2.29) | 19.11(10.33~31.30) | 28.26(14.65~48.10) | 0.48(0.14~0.91) |
女性 | 16.15(9.41~27.13) | 29.03(15.65~47.81) | 0.80(0.26~1.46) | 14.68(8.08~24.44) | 16.43(8.77~27.28) | 0.12(-0.18~0.47) |
25~49岁 | 1.44(0.69~2.45) | 2.00(0.99~3.21) | 0.38(0.04~0.91) | |||
50~69岁 | 20.43(11.31~33.13) | 18.83(10.69~29.40) | -0.08(-0.29~0.19) | |||
≥70岁 | 151.10(80.64~255.72) | 241.68(119.81~413.46) | 0.60(0.23~1.02) | |||
外周动脉疾病 | ||||||
总体 | 0.02(0.02~0.03) | 0.05(0.04~0.06) | 1.23(0.56~1.86) | 0.02(0.02~0.03) | 0.03(0.02~0.04) | 0.31(-0.08~0.66) |
男性 | 0.02(0.01~0.03) | 0.06(0.04~0.07) | 1.86(1.02~2.97) | 0.03(0.02~0.04) | 0.04(0.03~0.05) | 0.63(0.13~1.18) |
女性 | 0.02(0.01~0.03) | 0.03(0.02~0.05) | 0.63(-0.09~1.34) | 0.02(0.01~0.03) | 0.02(0.01~0.03) | -0.01(-0.44~0.39) |
25~49岁 | 0.00(0.00~0.00) | 0.00(0.00~0.00) | 0.89(0.24~1.75) | |||
50~69岁 | 0.03(0.02~0.04) | 0.03(0.02~0.04) | 0.18(-0.21~0.63) | |||
≥70岁 | 0.21(0.16~0.29) | 0.33(0.25~0.43) | 0.56(0.11~0.95) | |||
脑卒中 | ||||||
总体 | 33.71(22.23~49.60) | 34.42(21.89~53.95) | 0.02(-0.21~0.35) | 30.55(19.47~47.17) | 20.13(12.41~32.53) | -0.34(-0.49~-0.14) |
男性 | 32.28(21.34~48.23) | 41.18(25.41~65.81) | 0.28(-0.08~0.76) | 34.20(21.61~53.84) | 27.55(16.43~46.13) | -0.19(-0.41~0.08) |
女性 | 35.21(22.33~53.45) | 27.66(16.97~44.39) | -0.21(-0.45~0.10) | 28.30(17.52~44.84) | 14.78(8.95~24.28) | -0.48(-0.62~-0.27) |
25~49岁 | 2.01(0.90~3.58) | 1.81(0.86~3.10) | -0.10(-0.34~0.22) | |||
50~69岁 | 48.89(31.54~71.49) | 25.39(16.77~36.42) | -0.48(-0.60~-0.31) | |||
≥70岁 | 311.53(187.44~498.95) | 235.56(132.56~401.53) | -0.24(-0.43~0.02) | |||
25岁及以上人群分类 | DALY粗率 | 标化DALY率 | ||||
1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | |
缺血性心脏病 | ||||||
总体 | 344.52(212.33~535.71) | 578.04(362.74~894.38) | 0.68(0.32~1.14) | 276.80(171.38~427.71) | 326.68(200.79~507.53) | 0.18(-0.04~0.47) |
男性 | 366.93(224.66~550.69) | 701.37(436.70~1 090.43) | 0.91(0.43~1.64) | 320.34(191.66~491.75) | 434.88(259.71~687.70) | 0.36(0.04~0.77) |
女性 | 320.86(202.31~508.10) | 454.61(265.33~708.17) | 0.42(0.03~0.91) | 241.56(149.15~387.53) | 239.41(140.30~375.31) | -0.01(-0.27~0.31) |
25~49岁 | 72.41(34.08~123.38) | 98.76(47.86~160.45) | 0.36(0.03~0.86) | |||
50~69岁 | 604.63(335.08~952.88) | 563.39(316.77~855.80) | -0.07(-0.27~0.19) | |||
≥70岁 | 2 207.41(1 201.70~3 841.31) | 3 130.60(1 644.95~5 313.02) | 0.42(0.10~0.81) | |||
外周动脉疾病 | ||||||
总体 | 2.43(1.32~4.09) | 3.62(2.05~6.03) | 0.49(0.36~0.66) | 2.00(1.09~3.41) | 1.95(1.11~3.20) | -0.03(-0.11~0.07) |
男性 | 1.32(0.79~2.08) | 2.37(1.56~3.52) | 0.79(0.54~1.19) | 1.19(0.72~1.91) | 1.37(0.92~2.03) | 0.15(-0.01~0.41) |
女性 | 3.59(1.85~6.24) | 4.88(2.49~8.45) | 0.36(0.21~0.50) | 2.65(1.38~4.58) | 2.45(1.26~4.23) | -0.07(-0.17~0.02) |
25~49岁 | 0.04(0.03~0.07) | 0.08(0.06~0.11) | 0.86(0.24~1.70) | |||
50~69岁 | 4.19(2.19~7.20) | 4.08(2.19~7.00) | -0.02(-0.11~0.08) | |||
≥70岁 | 20.80(10.70~36.52) | 20.52(11.46~34.92) | -0.01(-0.10~0.11) | |||
脑卒中 | ||||||
总体 | 759.88(523.40~1 100.59) | 723.95(487.54~1 065.38) | -0.05(-0.25~0.24) | 576.95(387.33~834.76) | 385.97(256.13~577.25) | -0.33(-0.47~-0.15) |
男性 | 752.31(503.86~1 086.69) | 869.86(573.71~1 302.76) | 0.16(-0.15~0.58) | 622.59(413.11~923.29) | 496.71(320.45~763.41) | -0.20(-0.41~0.06) |
女性 | 767.87(500.23~1 127.54) | 577.93(374.62~863.55) | -0.25(-0.45~0.02) | 542.48(356.41~810.82) | 292.46(188.99~434.91) | -0.46(-0.60~-0.27) |
25~49岁 | 106.87(48.91~189.31) | 100.48(50.14~168.76) | -0.06(-0.29~0.25) | |||
50~69岁 | 1 456.39(940.60~2 114.25) | 816.72(543.89~1 167.06) | -0.44(-0.57~-0.27) | |||
≥70岁 | 4 939.47(3 013.23~7 801.27) | 3 662.37(2 066.96~6 023.36) | -0.26(-0.44~0.00) |
Table 3 The changes in mortality and DALY rates of three types of cardiovascular diseases attributable to diabetes in 1990 and 2019
25岁及以上人群分类 | 粗死亡率 | 标化死亡率 | ||||
---|---|---|---|---|---|---|
1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | |
缺血性心脏病 | ||||||
总体 | 15.83(9.71~24.88) | 32.84(18.62~53.62) | 1.07(0.59~1.68) | 16.36(9.05~26.27) | 21.10(11.47~35.35) | 0.29(0.04~0.59) |
男性 | 15.52(9.49~24.15) | 36.64(20.53~58.73) | 1.36(0.71~2.29) | 19.11(10.33~31.30) | 28.26(14.65~48.10) | 0.48(0.14~0.91) |
女性 | 16.15(9.41~27.13) | 29.03(15.65~47.81) | 0.80(0.26~1.46) | 14.68(8.08~24.44) | 16.43(8.77~27.28) | 0.12(-0.18~0.47) |
25~49岁 | 1.44(0.69~2.45) | 2.00(0.99~3.21) | 0.38(0.04~0.91) | |||
50~69岁 | 20.43(11.31~33.13) | 18.83(10.69~29.40) | -0.08(-0.29~0.19) | |||
≥70岁 | 151.10(80.64~255.72) | 241.68(119.81~413.46) | 0.60(0.23~1.02) | |||
外周动脉疾病 | ||||||
总体 | 0.02(0.02~0.03) | 0.05(0.04~0.06) | 1.23(0.56~1.86) | 0.02(0.02~0.03) | 0.03(0.02~0.04) | 0.31(-0.08~0.66) |
男性 | 0.02(0.01~0.03) | 0.06(0.04~0.07) | 1.86(1.02~2.97) | 0.03(0.02~0.04) | 0.04(0.03~0.05) | 0.63(0.13~1.18) |
女性 | 0.02(0.01~0.03) | 0.03(0.02~0.05) | 0.63(-0.09~1.34) | 0.02(0.01~0.03) | 0.02(0.01~0.03) | -0.01(-0.44~0.39) |
25~49岁 | 0.00(0.00~0.00) | 0.00(0.00~0.00) | 0.89(0.24~1.75) | |||
50~69岁 | 0.03(0.02~0.04) | 0.03(0.02~0.04) | 0.18(-0.21~0.63) | |||
≥70岁 | 0.21(0.16~0.29) | 0.33(0.25~0.43) | 0.56(0.11~0.95) | |||
脑卒中 | ||||||
总体 | 33.71(22.23~49.60) | 34.42(21.89~53.95) | 0.02(-0.21~0.35) | 30.55(19.47~47.17) | 20.13(12.41~32.53) | -0.34(-0.49~-0.14) |
男性 | 32.28(21.34~48.23) | 41.18(25.41~65.81) | 0.28(-0.08~0.76) | 34.20(21.61~53.84) | 27.55(16.43~46.13) | -0.19(-0.41~0.08) |
女性 | 35.21(22.33~53.45) | 27.66(16.97~44.39) | -0.21(-0.45~0.10) | 28.30(17.52~44.84) | 14.78(8.95~24.28) | -0.48(-0.62~-0.27) |
25~49岁 | 2.01(0.90~3.58) | 1.81(0.86~3.10) | -0.10(-0.34~0.22) | |||
50~69岁 | 48.89(31.54~71.49) | 25.39(16.77~36.42) | -0.48(-0.60~-0.31) | |||
≥70岁 | 311.53(187.44~498.95) | 235.56(132.56~401.53) | -0.24(-0.43~0.02) | |||
25岁及以上人群分类 | DALY粗率 | 标化DALY率 | ||||
1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | 1990年(1/10万) | 2019年(1/10万) | EAPC(95%CI)(%) | |
缺血性心脏病 | ||||||
总体 | 344.52(212.33~535.71) | 578.04(362.74~894.38) | 0.68(0.32~1.14) | 276.80(171.38~427.71) | 326.68(200.79~507.53) | 0.18(-0.04~0.47) |
男性 | 366.93(224.66~550.69) | 701.37(436.70~1 090.43) | 0.91(0.43~1.64) | 320.34(191.66~491.75) | 434.88(259.71~687.70) | 0.36(0.04~0.77) |
女性 | 320.86(202.31~508.10) | 454.61(265.33~708.17) | 0.42(0.03~0.91) | 241.56(149.15~387.53) | 239.41(140.30~375.31) | -0.01(-0.27~0.31) |
25~49岁 | 72.41(34.08~123.38) | 98.76(47.86~160.45) | 0.36(0.03~0.86) | |||
50~69岁 | 604.63(335.08~952.88) | 563.39(316.77~855.80) | -0.07(-0.27~0.19) | |||
≥70岁 | 2 207.41(1 201.70~3 841.31) | 3 130.60(1 644.95~5 313.02) | 0.42(0.10~0.81) | |||
外周动脉疾病 | ||||||
总体 | 2.43(1.32~4.09) | 3.62(2.05~6.03) | 0.49(0.36~0.66) | 2.00(1.09~3.41) | 1.95(1.11~3.20) | -0.03(-0.11~0.07) |
男性 | 1.32(0.79~2.08) | 2.37(1.56~3.52) | 0.79(0.54~1.19) | 1.19(0.72~1.91) | 1.37(0.92~2.03) | 0.15(-0.01~0.41) |
女性 | 3.59(1.85~6.24) | 4.88(2.49~8.45) | 0.36(0.21~0.50) | 2.65(1.38~4.58) | 2.45(1.26~4.23) | -0.07(-0.17~0.02) |
25~49岁 | 0.04(0.03~0.07) | 0.08(0.06~0.11) | 0.86(0.24~1.70) | |||
50~69岁 | 4.19(2.19~7.20) | 4.08(2.19~7.00) | -0.02(-0.11~0.08) | |||
≥70岁 | 20.80(10.70~36.52) | 20.52(11.46~34.92) | -0.01(-0.10~0.11) | |||
脑卒中 | ||||||
总体 | 759.88(523.40~1 100.59) | 723.95(487.54~1 065.38) | -0.05(-0.25~0.24) | 576.95(387.33~834.76) | 385.97(256.13~577.25) | -0.33(-0.47~-0.15) |
男性 | 752.31(503.86~1 086.69) | 869.86(573.71~1 302.76) | 0.16(-0.15~0.58) | 622.59(413.11~923.29) | 496.71(320.45~763.41) | -0.20(-0.41~0.06) |
女性 | 767.87(500.23~1 127.54) | 577.93(374.62~863.55) | -0.25(-0.45~0.02) | 542.48(356.41~810.82) | 292.46(188.99~434.91) | -0.46(-0.60~-0.27) |
25~49岁 | 106.87(48.91~189.31) | 100.48(50.14~168.76) | -0.06(-0.29~0.25) | |||
50~69岁 | 1 456.39(940.60~2 114.25) | 816.72(543.89~1 167.06) | -0.44(-0.57~-0.27) | |||
≥70岁 | 4 939.47(3 013.23~7 801.27) | 3 662.37(2 066.96~6 023.36) | -0.26(-0.44~0.00) |
Figure 1 The changes in the proportion of standardized DALY rates attributable to diabetes for cardiovascular diseases among the Chinese population aged 25 years and above from 1990 to 2019
[1] |
WHO. Global health risks:mortality and burden of disease attributable to selected major risks[EB/OL].(2019-09-10)[2022-05-25].
|
[2] |
钱佳慧,曹裴娅,吴侃,等. 慢性病对中国老年人日常生活活动能力影响的调查研究[J]. 中国全科医学,2016,19(35):4364-4369. DOI:10.3969/j.issn.1007-9572.2016.35.015.
|
[3] |
International Diabetes Federation.IDF Diabetes Atlas,10th ed[R]. Brussels,Belgium:International Diabetes Federation,2021.
|
[4] | |
[5] |
|
[6] |
《中国心血管健康与疾病报告》编写组. 《中国心血管健康与疾病报告2020》概述[J]. 中国心血管病研究,2021,19(7):582-590. DOI:10.3969/j.issn.1672-5301.2021.07.002.
|
[7] |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志,2023,38(6):583-612. DOI:10.3969/j.issn.1000-3614.2023.06.001.
|
[8] |
李小梅. 双心护理措施对糖尿病患者行冠心病介入治疗中遵医行为与心血管不良事件的影响研究[J]. 糖尿病新世界,2021,24(21):159-162,167. DOI:10.16658/j.cnki.1672-4062.2021.21.159.
|
[9] |
|
[10] |
The Academy of Medical Sciences. Multimorbidity:a priority for global health research[R/OL]. [2023-10-12].
|
[11] |
GBD Diabetes in The Americas Collaborators. Burden of diabetes and hyperglycaemia in adults in the Americas,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Diabetes Endocrinol,2022,10(9):655-667. DOI:10.1016/S2213-8587(22)00186-3.
|
[12] |
GBD Demographics Collaborators. Global age-sex-specific fertility,mortality,healthy life expectancy(HALE),and population estimates in 204 countries and territories,1950-2019:a comprehensive demographic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1160-1203. DOI:10.1016/S0140-6736(20)30977-6.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] | |
[22] |
林永兴,刘足云,李娜,等. 1990—2019年浙江省心血管疾病负担变化趋势[J]. 预防医学,2022,34(10):1020-1025. DOI:10.19485/j.cnki.issn2096-5087.2022.10.010.
|
[23] |
|
[1] | JIN Menglong, QIN Xiaoying, MALIYA Amiti, JIAZINI Nuerbai, LI Jianxin, CAO Jie, LUO Sifu, LIU Cheng, ZHANG Yuchen, GAI Mintao, LI Yanpeng, LU Xiangfeng, FU Zhenyan. Status and Influencing Factors of Dyslipidemia, Hypertension and Diabetes Comorbidities among Kazakhs in Xinjiang [J]. Chinese General Practice, 2024, 27(12): 1438-1444. |
[2] | SHI Weili, LI Mingyan, DUAN Hongyan. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Interpretation of the U.S. Preventive Services Task Force Recommendation Statement [J]. Chinese General Practice, 2024, 27(12): 1405-1412. |
[3] | ZENG Lingfeng, ZHANG Hui, LEI Si, ZHUO Hui, YE Yun, XU Yan, LUO Yingquan. Obstructive Sleep Apnea in Adults Screening: Interpretation of the U.S. Preventive Services Task Force Recommendation Statement [J]. Chinese General Practice, 2024, 27(12): 1412-1416. |
[4] | LI Mingyan, SHI Weili, DUAN Hongyan. Aspirin Use to Prevent Cardiovascular Disease in Adults: Interpretation of U.S. Preventive Services Task Force Recommendations Statement [J]. Chinese General Practice, 2024, 27(11): 1277-1282. |
[5] | XU Li, GE Jing, YU Peng, YU Ying. Shifts in Chronic Disease and Comorbidity Patterns among Chinese Older Adults: an Analysis Based on the China Health and Retirement Longitudinal Study [J]. Chinese General Practice, 2024, 27(11): 1296-1302. |
[6] | ZHANG Shengnan, XU Shihua, HUANG Rongchao, CHEN Jian, ZHAO Chunru, MENG Minglyu, MA Yingjiao. Trend and Forecast Analysis of Premature Mortality Probability by Four Major Non-communicable Diseases in Baise from 2015 to 2021 [J]. Chinese General Practice, 2024, 27(11): 1387-1394. |
[7] | HE Yufu, TONG Wenying, WANG Fang, LI Lixia, HE Junbing, SHAO Yiming. Effects of Pre-hospital Metformin Use on Clinical Outcomes in Patients with Diabetes and Sepsis [J]. Chinese General Practice, 2024, 27(09): 1034-1041. |
[8] | WANG Xueting, JIANG Yi. Disease Burden of Chronic Obstructive Pulmonary Disease in the BRICS Countries from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(09): 1118-1125. |
[9] | HAN Junjie, WU Di, CHEN Zhisheng, XIAO Yang, SEN Gan. A Nomogram Prediction Model and Validation Study on the Risk of Complicated Diabetic Nephropathy in Type 2 Diabetes Patients [J]. Chinese General Practice, 2024, 27(09): 1054-1061. |
[10] | LI Ziyue, FANG Jiawen, LIN Kaicheng. Analysis and Prediction of the Disease Burden of Type 2 Diabetes Attributable to High Body Mass Index in China from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(09): 1126-1133. |
[11] | ZHANG Jinyi, ZHANG Shizhong. Advances in Epidemiology and Related Mechanisms of Cardiovascular Diseases and Mental Illness [J]. Chinese General Practice, 2024, 27(08): 893-899. |
[12] | ZOU Qiong, WU Xi, ZHANG Yang, WAN Yi, CHEN Changsheng. Prediction of Type 2 Diabetic Nephropathy Based on BP Neural Network Optimized by Sparrow Search Algorithm [J]. Chinese General Practice, 2024, 27(08): 961-970. |
[13] | GAO Yuan, ZHOU Min, QIN Manfen, XU Xuan, YANG Liping, FU Yahong, HUANG Ying, WANG Wei. Effects of Health Coaching Combined with Wearable Devices on Glucose and Lipid Metabolism and Self-management Behavior in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2024, 27(08): 908-914. |
[14] | LUO Yuanxin, PENG Derong, ZHANG Lin, LIU Haiying, TAN Jun. Correlation between Snoring and 10-year Risk of Atherosclerotic Cardiovascular Disease in Middle-aged and Elderly Population [J]. Chinese General Practice, 2024, 27(07): 810-815. |
[15] | YAO Mi, LIN Kai, FAN Jieting, JI Xinxin, WANG Ying, DONG Aimei, HAN Xiaoning, QI Jianguang, CHI Chunhua, Haroon Shamil, Jackson Dawn, Cheng KK, Lehman Richard. Design and Development of Communication Skills Training in Diabetes Care for General Practitioners in China [J]. Chinese General Practice, 2024, 27(07): 816-821. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||